Works matching IS 00070920 AND DT 2008 AND VI 99 AND IP 8

Results: 30

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis.

Published in:

2008

By:

Thurston, G;
Kitajewski, J

Publication type:

journal article

Endometrial stromal sarcoma: a population-based analysis.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1210, doi. 10.1038/sj.bjc.6604527

By:

Chan, J K;
Kawar, N M;
Shin, J Y;
Osann, K;
Chen, L-m;
Powell, C B;
Kapp, D S

Publication type:

Article

Identification of novel neuroendocrine-specific tumour genes.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1330, doi. 10.1038/sj.bjc.6604565

By:

Hofsli, E;
Wheeler, T E;
Langaas, M;
Lægreid, A;
Thommesen, L

Publication type:

Article

Adjuvant hysterectomy for treatment of residual disease in patients with cervical cancer treated with radiation therapy.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1216, doi. 10.1038/sj.bjc.6604619

By:

Ota, T;
Takeshima, N;
Tabata, T;
Hasumi, K;
Takizawa, K

Publication type:

Article

mTORC1 inhibitors: is temsirolimus in renal cancer telling us how they really work?

Published in:

2008

By:

Le Tourneau, C;
Faivre, S;
Serova, M;
Raymond, E

Publication type:

journal article

A novel AKT3 mutation in melanoma tumours and cell lines.

Published in:

2008

By:

Davies, M A;
Stemke-Hale, K;
Tellez, C;
Calderone, T L;
Deng, W;
Prieto, V G;
Lazar, A J F;
Gershenwald, J E;
Mills, G B

Publication type:

journal article

In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2.

Published in:

2008

By:

Kim, S;
Mohapatra, G;
Haber, D A

Publication type:

journal article

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.

Published in:

2008

By:

Tirelli, U

Publication type:

commentary

Reply: Clinical outcome and prognostic factors for patients treated within a phase I study: the Royal Marsden Hospital Experience.

Published in:

2008

By:

Olmos, D;
Arkenau, H-T;
Ang, J E;
de Bono, J S;
Judson, I;
Kaye, S B

Publication type:

Letter

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1269, doi. 10.1038/sj.bjc.6604650

By:

Mahner, S;
Baasch, C;
Schwarz, J;
Hein, S;
Wölber, L;
Jänicke, F;
Milde-Langosch, K

Publication type:

Article

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.

Published in:

2008

By:

Kweekel, D M;
Koopman, M;
Antonini, N F;
Van der Straaten, T;
Nortier, J W R;
Gelderblom, H;
Punt, C J A;
Guchelaar, H-J

Publication type:

journal article

Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas.

Published in:

2008

By:

Shastri, Y M;
Stein, J M

Publication type:

Letter

Resistance to chemotherapy.

Published in:

2008

By:

Hofmann, J

Publication type:

commentary

CD133 expression is an independent prognostic marker for low survival in colorectal cancer.

Published in:

2008

By:

Horst, D;
Kriegl, L;
Engel, J;
Kirchner, T;
Jung, A

Publication type:

journal article

PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients.

Published in:

2008

By:

Harwood, C A;
Attard, N R;
O'Donovan, P;
Chambers, P;
Perrett, C M;
Proby, C M;
McGregor, J M;
Karran, P

Publication type:

journal article

Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer.

Published in:

2008

By:

Hisashige, A;
Yoshida, S;
Kodaira, S

Publication type:

journal article

Breast cancer awareness among older women.

Published in:

2008

By:

Linsell, L;
Burgess, C C;
Ramirez, A J

Publication type:

journal article

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients.

Published in:

2008

By:

Rouits, E;
Charasson, V;
Pétain, A;
Boisdron-Celle, M;
Delord, J-P;
Fonck, M;
Laurand, A;
Poirier, A-L;
Morel, A;
Chatelut, E;
Robert, J;
Gamelin, E;
Pétain, A

Publication type:

journal article

NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life.

Published in:

2008

By:

Earl, H M;
Hiller, L;
Dunn, J A;
Bathers, S;
Harvey, P;
Stanley, A;
Grieve, R J;
Agrawal, R K;
Fernando, I N;
Brunt, A M;
McAdam, K;
O'Reilly, S;
Rea, D W;
Spooner, D;
Poole, C J;
NEAT Investigators

Publication type:

journal article

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.

Published in:

2008

By:

Fens, M H A M;
Hill, K J;
Issa, J;
Ashton, S E;
Westwood, F R;
Blakey, D C;
Storm, G;
Ryan, A J;
Schiffelers, R M

Publication type:

journal article

High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

Published in:

2008

By:

Fong, D;
Moser, P;
Krammel, C;
Gostner, J M;
Margreiter, R;
Mitterer, M;
Gastl, G;
Spizzo, G

Publication type:

journal article

Reply: Faecal tumour pyruvate kinase M2: not a good marker for detection of colorectal adenomas.

Published in:

2008

By:

Haug, U;
Hundt, S;
Brenner, H

Publication type:

Letter

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

Published in:

2008

By:

McCall, P;
Witton, C J;
Grimsley, S;
Nielsen, K V;
Edwards, J

Publication type:

journal article

Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1307, doi. 10.1038/sj.bjc.6604682

By:

Takeno, A;
Takemasa, I;
Doki, Y;
Yamasaki, M;
Miyata, H;
Takiguchi, S;
Fujiwara, Y;
Matsubara, K;
Monden, M

Publication type:

Article

Case–control study and meta-analysis of SULT1A1 Arg<sup>213</sup>His polymorphism for gene, ethnicity and environment interaction for cancer risk.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1340, doi. 10.1038/sj.bjc.6604683

By:

Kotnis, A;
Kannan, S;
Sarin, R;
Mulherkar, R

Publication type:

Article

Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1348, doi. 10.1038/sj.bjc.6604685

By:

Ohradanova, A;
Gradin, K;
Barathova, M;
Zatovicova, M;
Holotnakova, T;
Kopacek, J;
Parkkila, S;
Poellinger, L;
Pastorekova, S;
Pastorek, J

Publication type:

Article

NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.

Published in:

2008

By:

Murray, D;
Horgan, G;
MacMathuna, P;
Doran, P

Publication type:

journal article

TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1357, doi. 10.1038/sj.bjc.6604689

By:

Mu, L;
Katsaros, D;
Lu, L;
Preti, M;
Durando, A;
Arisio, R;
Yu, H

Publication type:

Article

Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells.

Published in:

British Journal of Cancer, 2008, v. 99, n. 8, p. 1246, doi. 10.1038/sj.bjc.6604692

By:

Treeck, O;
Lattrich, C;
Juhasz-Boess, I;
Buchholz, S;
Pfeiler, G;
Ortmann, O

Publication type:

Article

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype.

Published in:

2008

By:

Helsby, N A;
Lo, W-Y;
Sharples, K;
Riley, G;
Murray, M;
Spells, K;
Dzhelai, M;
Simpson, A;
Findlay, M

Publication type:

journal article